Search Results - "Chimeric antigen receptor T cell"

Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma by Albert Jang, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang, Pedro C. Barata

Connect to this object online.

Current and emerging therapies for primary central nervous system lymphoma by Yan Yuan, Tianling Ding, Shu Wang, Hong Chen, Ying Mao, Tong Chen

Connect to this object online.

Immunotherapies for Acute Myeloid Leukemia

DOAB: download the publication
DOAB: description of the publication

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond by Adriana Balduzzi, Jochen Buechner, Marianne Ifversen, Jean-Hugues Dalle, Anca M. Colita, Marc Bierings

Connect to this object online.

A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia by Melissa Gabriel, Bianca A. W. Hoeben, Bianca A. W. Hoeben, Hilde Hylland Uhlving, Olga Zajac-Spychala, Anita Lawitschka, Dorine Bresters, Marianne Ifversen

Connect to this object online.

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy by Weizhen Li, Weizhen Li, Yang Zhou, Zhongen Wu, Yaoping Shi, Enming Tian, Yingqi Zhu, Tao Wang, Wei Dou, Xiangjing Meng, Xiangjing Meng, Ming Chen, Ming Chen, Bo Zhai, Bo Zhai, Di Zhu, Di Zhu

Connect to this object online.

Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen by Richard Harrop, Eric O'Neill, Peter L. Stern

Connect to this object online.

What Is the Role of HSCT in Philadelphia-Chromosome-Positive and Philadelphia-Chromosome-Like ALL in the Tyrosine Kinase Inhibitor Era? by Kim Vettenranta, Veronika Dobsinska, Gabriella Kertész, Peter Svec, Jochen Buechner, Kirk R. Schultz

Connect to this object online.

"Stapling" scFv for multispecific biotherapeutics of superior properties by Lauren E. Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, Fang Yi, Rupesh Nanjunda, Sheng-Jiun Wu, Tun Liu, Eilyn R. Lacy, Steven Jacobs, Natalia Kozlyuk, Brian Del Rosario, Bingyuan Wu, Patricia Aquino, Robert C. Davidson, Samantha Heyne, Nicholas Mazzanti, James Testa, Michael D. Diem, Elsa Gorre, Andrew Mahan, Hirsh Nanda, Harsha P. Gunawardena, Alexis Gervais, Anthony A. Armstrong, Alexey Teplyakov, Chichi Huang, Adam Zwolak, Partha Chowdhury, Wan Cheung Cheung, Jinquan Luo

Connect to this object online.

Aggressive Diffuse Intermediate Size B-Cell Lymphoma With P53 Mutation Presented as Primary Bone Marrow Lymphoma by Pei Ting Chen MD, Karan Jorsan MD, Boris Avezbakiyev MD, Cheema Akhtar MD, Jen Chin Wang MD

Connect to this object online.

Structural basis for antibody recognition of the proximal MUC16 ectodomain by Kwangkook Lee, Kay Perry, Mengyao Xu, Irva Veillard, Raj Kumar, Thapi Dharma Rao, Bo R Rueda, David R Spriggs, Oladapo O Yeku

Connect to this object online.

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma by Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang

Connect to this object online.

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy by Wei Mu, Wei Mu, Xiaolu Long, Xiaolu Long, Haodong Cai, Haodong Cai, Caixia Chen, Caixia Chen, Guang Hu, Yaoyao Lou, Shugang Xing, Shugang Xing, Di Wang, Di Wang, Jue Wang, Jue Wang, Min Xiao, Min Xiao, Kun Wang, Zhongyi Sun, Chunrui Li, Chunrui Li, Jianfeng Zhou, Jianfeng Zhou, Liting Chen, Liting Chen

Connect to this object online.

Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study by Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi

Connect to this object online.

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transpla... by Meng-Yun Li, Zhi-Hong Lin, Ming-Ming Hu, Li-Qing Kang, Xiao-xia Wu, Qi-wei Chen, Xin Kong, Jian Zhang, Hui-Ying Qiu, De-Pei Wu

Connect to this object online.

Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy by Fang Xie, Luchen Zhang, Sanyuan Shi, Anjie Zheng, Jiaxing Di, Shanshan Jin, Xuguang Miao, Fenglan Wu, Xiaolong Chen, Yanhong Zhang, Xiaohui Wei, Yuhong Xu

Connect to this object online.

Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model by Aman P. Singh, Xirong Zheng, Xiefan Lin-Schmidt, Wenbo Chen, Thomas J. Carpenter, Alice Zong, Weirong Wang, Donald L. Heald

Connect to this object online.

Development of T-cell engagers selective for cells co-expressing two antigens by Danielle M. Dicara, Sunil Bhakta, Mary Ann Go, James Ziai, Ron Firestein, Bill Forrest, Chen Gu, Steven R. Leong, Genee Lee, Shang-Fan Yu, Andrew G. Polson, Nicholas J. Agard

Connect to this object online.